Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN67135334) titled 'Study to assess the pharmacokinetics, tolerability, and food effect of PTC923 in healthy subjects' on July 31.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Active
Assignment: Single
Purpose: Pharmacokinetics, tolerability, and food effect of PTC923
Primary Sponsor: PTC Therapeutics (United States)
Condition:
Healthy participants
Other
Intervention:
A single-dose study of orally administered PTC923 in 60 healthy adults (30 Japanese and 30 non-Japanese subjects) equally divided into 5 cohorts (20, 40 x2, and 60 mg x2/kg), each composed of ...